186 related articles for article (PubMed ID: 38532996)
1. Prognostic insights and immune microenvironment delineation in acute myeloid leukemia by ferroptosis-derived signature.
Jing L; Zhang B; Sun J; Feng J; Fu D
Heliyon; 2024 Mar; 10(6):e28237. PubMed ID: 38532996
[TBL] [Abstract][Full Text] [Related]
2. Molecular subtyping of acute myeloid leukemia through ferroptosis signatures predicts prognosis and deciphers the immune microenvironment.
Fu D; Zhang B; Wu S; Feng J; Jiang H
Front Cell Dev Biol; 2023; 11():1207642. PubMed ID: 37691822
[TBL] [Abstract][Full Text] [Related]
3. A novel ferroptosis-related gene signature can predict prognosis and influence immune microenvironment in acute myeloid leukemia.
Huang X; Zhou D; Ye X; Jin J
Bosn J Basic Med Sci; 2022 Jul; 22(4):608-628. PubMed ID: 34784264
[TBL] [Abstract][Full Text] [Related]
4. Prognosis and Characterization of Immune Microenvironment in Acute Myeloid Leukemia Through Identification of an Autophagy-Related Signature.
Fu D; Zhang B; Wu S; Zhang Y; Xie J; Ning W; Jiang H
Front Immunol; 2021; 12():695865. PubMed ID: 34135913
[TBL] [Abstract][Full Text] [Related]
5. A Comprehensive Metabolism-Related Gene Signature Predicts the Survival of Patients with Acute Myeloid Leukemia.
Zhai Y; Shen H; Wei H
Genes (Basel); 2023 Dec; 15(1):. PubMed ID: 38254953
[TBL] [Abstract][Full Text] [Related]
6. A novel 10-gene ferroptosis-related prognostic signature in acute myeloid leukemia.
Zhu K; Lang Z; Zhan Y; Tao Q; Yu Z; Chen L; Fan C; Jin Y; Yu K; Zhu B; Gao Y; Wang C; Jiang S; Shi Y
Front Oncol; 2022; 12():1023040. PubMed ID: 36338716
[TBL] [Abstract][Full Text] [Related]
7. Novel Prognostic Signature for Acute Myeloid Leukemia: Bioinformatics Analysis of Combined CNV-Driven and Ferroptosis-Related Genes.
Han C; Zheng J; Li F; Guo W; Cai C
Front Genet; 2022; 13():849437. PubMed ID: 35559049
[No Abstract] [Full Text] [Related]
8. Dipetidyl peptidase-4 and transferrin receptor serve as prognostic biomarkers for acute myeloid leukemia.
Wei J; Nai GY; Dai Y; Huang XJ; Xiong MY; Yao XY; Huang ZN; Li SN; Zhou WJ; Huang Y; Cheng P; Deng DH
Ann Transl Med; 2021 Sep; 9(17):1381. PubMed ID: 34733933
[TBL] [Abstract][Full Text] [Related]
9. Risk stratification of acute myeloid leukemia: Assessment using a novel prediction model based on ferroptosis-immune related genes.
Guo X; Zhou X
Math Biosci Eng; 2022 Aug; 19(12):11821-11839. PubMed ID: 36653976
[TBL] [Abstract][Full Text] [Related]
10. Identification of clinical prognostic factors and analysis of ferroptosis-related gene signatures in the bladder cancer immune microenvironment.
Ma J; Hu J; Zhao L; Wu Z; Li R; Deng W
BMC Urol; 2024 Jan; 24(1):6. PubMed ID: 38172792
[TBL] [Abstract][Full Text] [Related]
11. HIVEP3 cooperates with ferroptosis gene signatures to confer adverse prognosis in acute myeloid leukemia.
Zhang X; Zhang X; Liu K; Li W; Wang J; Liu P; Ma W
Cancer Med; 2022 Dec; 11(24):5050-5065. PubMed ID: 35535739
[TBL] [Abstract][Full Text] [Related]
12. A transient receptor potential channel-related model based on machine learning for evaluating tumor microenvironment and immunotherapeutic strategies in acute myeloid leukemia.
Hua J; Ding T; Shao Y
Front Immunol; 2022; 13():1040661. PubMed ID: 36591215
[TBL] [Abstract][Full Text] [Related]
13. Construction and Validation of a Novel Ferroptosis-Related Prognostic Model for Acute Myeloid Leukemia.
Song Y; Tian S; Zhang P; Zhang N; Shen Y; Deng J
Front Genet; 2021; 12():708699. PubMed ID: 35111195
[TBL] [Abstract][Full Text] [Related]
14. A prognostic model based on prognosis-related ferroptosis genes for patients with acute myeloid leukemia.
Wu F; Xu G; Li G; Yin Z; Shen H; Ye K; Zhu Y; Zhang Q; Ou R; Liu S
Front Mol Biosci; 2023; 10():1281141. PubMed ID: 38161382
[No Abstract] [Full Text] [Related]
15. Construction of A Novel Ferroptosis-related Prognostic Risk Signature for Survival Prediction in Clear Cell Renal Cell Carcinoma Patients.
Tang F; Zhang J; Zhu L; Lai Y; Li Z; Lu Z; Tang Z; Mai Y; Huang R; He Z
Urol J; 2022 May; 19(4):289-299. PubMed ID: 35598038
[TBL] [Abstract][Full Text] [Related]
16. Identification and Validation of a Prognostic Risk-Scoring Model Based on Ferroptosis-Associated Cluster in Acute Myeloid Leukemia.
Wang J; Zhuo Z; Wang Y; Yang S; Chen J; Wang Y; Geng S; Li M; Du X; Lai P; Weng J
Front Cell Dev Biol; 2021; 9():800267. PubMed ID: 35127715
[No Abstract] [Full Text] [Related]
17. A ferroptosis-related signature predicts the clinical diagnosis and prognosis, and associates with the immune microenvironment of lung cancer.
Zhou H; Zhou X; Zhu R; Zhao Z; Yang K; Shen Z; Sun H
Discov Oncol; 2024 May; 15(1):163. PubMed ID: 38743344
[TBL] [Abstract][Full Text] [Related]
18. Combination of ferroptosis and pyroptosis to construct a prognostic classifier and predict immune landscape, chemotherapeutic efficacy and immunosuppressive molecules in hepatocellular carcinoma.
Xu L; Zheng Q; Liu W
BMC Cancer; 2022 Mar; 22(1):229. PubMed ID: 35236323
[TBL] [Abstract][Full Text] [Related]
19. A novel fatty acid metabolism-related signature identifies features of the tumor microenvironment and predicts clinical outcome in acute myeloid leukemia.
Zhang HB; Sun ZK; Zhong FM; Yao FY; Liu J; Zhang J; Zhang N; Lin J; Li SQ; Li MY; Jiang JY; Cheng Y; Xu S; Cheng XX; Huang B; Wang XZ
Lipids Health Dis; 2022 Aug; 21(1):79. PubMed ID: 36002858
[TBL] [Abstract][Full Text] [Related]
20. Establishment and validation of a carbohydrate metabolism-related gene signature for prognostic model and immune response in acute myeloid leukemia.
Yang Y; Yang Y; Liu J; Zeng Y; Guo Q; Guo J; Guo L; Lu H; Liu W
Front Immunol; 2022; 13():1038570. PubMed ID: 36544784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
